Safety Study of GRNOPC1 in Spinal Cord Injury
| Status: | Archived |
|---|---|
| Conditions: | Hospital, Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2010 |
| End Date: | October 2012 |
A Phase 1 Safety Study of GRNOPC1 in Patients With Neurologically Complete, Subacute, Spinal Cord Injury
The purpose of the study is to evaluate the safety of GRNOPC1 administered at a single
time-point between 7 and 14 days post injury, inclusive, to patients with neurologically
complete spinal cord injuries (SCI).
We found this trial at
4
sites
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials